Paclitaxel/Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of paclitaxel and pembrolizumab that can be used for the treatment of recurrent and metastatic hormone receptor-negative, HER-2 (EGFR2; ErbB2)-negative and PD-L1-positive breast cancer, head and neck cancer, ovarian, fallopian tube, and primary peritoneal cancer.

**Synonyms:** - Keytruda/Paclitaxel - Paclitaxel and Pembrolizumab - Paclitaxel-Pembrolizumab - Paclitaxel-Pembrolizumab Regimen - Paclitaxel/Pembrolizumab - Pembrolizumab Plus Paclitaxel - Pembrolizumab-Paclitaxel - Pembrolizumab/Paclitaxel - Pembrolizumab/Paclitaxel Regimen - Taxol/Keytruda